Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Gross Margin (2022 - 2025)

Historic Gross Margin for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to 3920.0%.

  • PAVmed's Gross Margin changed N/A to 3920.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 2737.93%, marking a year-over-year change of. This contributed to the annual value of 288.21% for FY2024, which is 3288700.0% up from last year.
  • Per PAVmed's latest filing, its Gross Margin stood at 3920.0% for Q3 2025.
  • Over the past 5 years, PAVmed's Gross Margin peaked at 95.24% during Q1 2022, and registered a low of 6131.58% during Q3 2022.
  • In the last 4 years, PAVmed's Gross Margin had a median value of 1450.0% in 2024 and averaged 2156.88%.
  • As far as peak fluctuations go, PAVmed's Gross Margin surged by 57238700bps in 2023, and later tumbled by -32333700bps in 2025.
  • Quarter analysis of 4 years shows PAVmed's Gross Margin stood at 5041.96% in 2022, then surged by 93bps to 347.09% in 2023, then tumbled by -318bps to 1450.0% in 2024, then tumbled by -170bps to 3920.0% in 2025.
  • Its last three reported values are 3920.0% in Q3 2025, 3566.67% for Q2 2025, and 2987.5% during Q1 2025.